147 related articles for article (PubMed ID: 22153631)
21. Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up.
Yue H; Qian J; Yuan Y; Zhang R; Bi Y; Meng F; Xuan Y
Curr Eye Res; 2017 May; 42(5):759-765. PubMed ID: 27911584
[TBL] [Abstract][Full Text] [Related]
22. Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.
Blom DJ; Luyten GP; Mooy C; Kerkvliet S; Zwinderman AH; Jager MJ
Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1865-72. PubMed ID: 9286277
[TBL] [Abstract][Full Text] [Related]
23. Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma.
Mäkitie T; Summanen P; Tarkkanen A; Kivelä T
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1414-21. PubMed ID: 11381040
[TBL] [Abstract][Full Text] [Related]
24. Tumor, node, metastasis classification of malignant ciliary body and choroidal melanoma evaluation of the 6th edition and future directions.
Kujala E; Kivelä T
Ophthalmology; 2005 Jun; 112(6):1135-44. PubMed ID: 15885792
[TBL] [Abstract][Full Text] [Related]
25. Microcirculation and tumor-infiltrating macrophages in choroidal and ciliary body melanoma and corresponding metastases.
Toivonen P; Mäkitie T; Kujala E; Kivelä T
Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):1-6. PubMed ID: 14691146
[TBL] [Abstract][Full Text] [Related]
26. Metastasis-free survival following treatment for uveal melanoma with either stereotactic radiosurgery or enucleation.
Cohen VM; Carter MJ; Kemeny A; Radatz M; Rennie IG
Acta Ophthalmol Scand; 2003 Aug; 81(4):383-8. PubMed ID: 12859266
[TBL] [Abstract][Full Text] [Related]
27. Expression of insulin-like growth factor receptor (IGF-1R), c-Fos, and c-Jun in uveal melanoma: an immunohistochemical study.
Mallikarjuna K; Pushparaj V; Biswas J; Krishnakumar S
Curr Eye Res; 2006 Oct; 31(10):875-83. PubMed ID: 17050279
[TBL] [Abstract][Full Text] [Related]
28. Intraocular lymphangiogenesis in malignant melanomas of the ciliary body with extraocular extension.
Heindl LM; Hofmann TN; Knorr HL; Rummelt C; Schrödl F; Schlötzer-Schrehardt U; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Invest Ophthalmol Vis Sci; 2009 May; 50(5):1988-95. PubMed ID: 19151383
[TBL] [Abstract][Full Text] [Related]
29. The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells.
Girnita A; All-Ericsson C; Economou MA; Aström K; Axelson M; Seregard S; Larsson O; Girnita L
Acta Ophthalmol; 2008 Nov; 86 Thesis 4():26-34. PubMed ID: 19032679
[TBL] [Abstract][Full Text] [Related]
30. Expression of epidermal growth factor receptor, ezrin, hepatocyte growth factor, and c-Met in uveal melanoma: an immunohistochemical study.
Mallikarjuna K; Pushparaj V; Biswas J; Krishnakumar S
Curr Eye Res; 2007 Mar; 32(3):281-90. PubMed ID: 17453948
[TBL] [Abstract][Full Text] [Related]
31. Expression of vascular endothelial growth factor a, matrix metalloproteinase 9 and extravascular matrix patterns in iris and ciliary body melanomas.
Sahin A; Kiratli H; Tezel GG; Soylemezoglu F; Bilgic S
Ophthalmic Res; 2007; 39(1):40-4. PubMed ID: 17164576
[TBL] [Abstract][Full Text] [Related]
32. Metastatic melanoma death rates by anatomic site after proton beam irradiation for uveal melanoma.
Li W; Gragoudas ES; Egan KM
Arch Ophthalmol; 2000 Aug; 118(8):1066-70. PubMed ID: 10922199
[TBL] [Abstract][Full Text] [Related]
33. Melanoma associated spongiform scleropathy: characterization, biochemical and immunohistochemical studies.
Alyahya GA
Acta Ophthalmol; 2008 Oct; 86 Thesis 3():1-21. PubMed ID: 18826517
[TBL] [Abstract][Full Text] [Related]
34. Expression of epidermal growth factor receptor: risk factor in uveal melanoma.
Hurks HM; Metzelaar-Blok JA; Barthen ER; Zwinderman AH; De Wolff-Rouendaal D; Keunen JE; Jager MJ
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2023-7. PubMed ID: 10892838
[TBL] [Abstract][Full Text] [Related]
35. PC-10 as a predictor of prognosis after antigen retrieval in posterior uveal melanoma.
Seregard S; Oskarsson M; Spångberg B
Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1451-8. PubMed ID: 8641848
[TBL] [Abstract][Full Text] [Related]
36. Relative importance of quantifying area and vascular patterns in uveal melanomas.
Mehaffey MG; Folberg R; Meyer M; Bentler SE; Hwang T; Woolson R; Moore KC
Am J Ophthalmol; 1997 Jun; 123(6):798-809. PubMed ID: 9535624
[TBL] [Abstract][Full Text] [Related]
37. Possible implications of MCAM expression in metastasis and non-metastatic of primary uveal melanoma patients.
Beutel J; Wegner J; Wegner R; Ziemssen F; Nassar K; Rohrbach JM; Hilgers RD; Lüke M; Grisanti S
Curr Eye Res; 2009 Nov; 34(11):1004-9. PubMed ID: 19958117
[TBL] [Abstract][Full Text] [Related]
38. HSP-27 protein expression in uveal melanoma: correlation with predicted survival.
Jmor F; Kalirai H; Taktak A; Damato B; Coupland SE
Acta Ophthalmol; 2012 Sep; 90(6):534-9. PubMed ID: 21114636
[TBL] [Abstract][Full Text] [Related]
39. Prognostic accuracy of the mean of the largest nucleoli, vascular patterns, and PC-10 in posterior uveal melanoma.
Seregard S; Spångberg B; Juul C; Oskarsson M
Ophthalmology; 1998 Mar; 105(3):485-91. PubMed ID: 9499780
[TBL] [Abstract][Full Text] [Related]
40. The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells.
Girnita A; All-Ericsson C; Economou MA; Aström K; Axelson M; Seregard S; Larsson O; Girnita L
Clin Cancer Res; 2006 Feb; 12(4):1383-91. PubMed ID: 16489097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]